A

Apex Healthcare Bhd
KLSE:AHEALTH

Watchlist Manager
Apex Healthcare Bhd
KLSE:AHEALTH
Watchlist
Price: 2.45 MYR 1.24%
Market Cap: 1.8B MYR
Have any thoughts about
Apex Healthcare Bhd?
Write Note

Apex Healthcare Bhd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Apex Healthcare Bhd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
A
Apex Healthcare Bhd
KLSE:AHEALTH
Revenue
myr964.3m
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
7%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Revenue
myr176.9m
CAGR 3-Years
3%
CAGR 5-Years
13%
CAGR 10-Years
13%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Revenue
myr217.4m
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Revenue
myr364.5m
CAGR 3-Years
9%
CAGR 5-Years
4%
CAGR 10-Years
7%
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Revenue
myr787.5m
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
16%
K
Kotra Industries Bhd
KLSE:KOTRA
Revenue
myr238.8m
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
5%
No Stocks Found

Apex Healthcare Bhd
Glance View

Market Cap
1.8B MYR
Industry
Pharmaceuticals

Apex Healthcare Bhd.is an investment holding company, which engages in the manufacture and trade of pharmaceutical and consumer healthcare products. The company is headquartered in Malacca, Melaka. The company went IPO on 2000-06-26. The firm operates through three segments: Manufacturing, Distribution, and Corporate. The Manufacturing segment is engaged in manufacturing and marketing of pharmaceutical products. The Distribution segment is engaged in wholesale, marketing, and distribution of pharmaceutical, consumer healthcare products and medical devices. The Corporate segment comprising investments, properties and others. The company develops manufacture and market XEPA branded off-patent generic pharmaceuticals and medical devices. The company also conducts contract manufacturing for pharmaceutical companies. The company provides specialist market access services for pharmaceutical companies through the provision of regulatory, redressing, sales, marketing and logistics services via a network of eight distribution facilities in Singapore and Malaysia. Its subsidiaries include Xepa-Soul Pattinson (Malaysia) Sdn. Bhd., Apex Pharmacy Marketing Sdn. Bhd. and ABio Marketing Sdn. Bhd.

AHEALTH Intrinsic Value
2.61 MYR
Undervaluation 6%
Intrinsic Value
Price
A

See Also

What is Apex Healthcare Bhd's Revenue?
Revenue
964.3m MYR

Based on the financial report for Sep 30, 2024, Apex Healthcare Bhd's Revenue amounts to 964.3m MYR.

What is Apex Healthcare Bhd's Revenue growth rate?
Revenue CAGR 10Y
7%

Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for Apex Healthcare Bhd have been 9% over the past three years , 7% over the past five years , and 7% over the past ten years .

Back to Top